The Office for Life Sciences (OLS) will work with Innovate UK, as part of UK Research and Innovation, to invest up to £1.5 million in innovation projects. These will be to support developers of innovative medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.
You can choose from 2 options:
- Planning and preparation for a study. Project costs can be up to £50,000.
- A study to collect clinical performance and cost-effectiveness data. Project costs can be up to £250,000.
All projects must be business led.
This competition aims to provide support for micro, small and medium-sized enterprises (SMEs). We are looking for studies that aim to develop an evidence base for products that address NHS priorities. Our support will allow companies to collect and analyse clinical performance and cost effectiveness data in an NHS setting.
You can work alone or collaborate with others as unfunded partners or sub-contractors. Only the lead partner can claim grant funding.If your project’s total costs or duration fall outside of our eligibility criteria, you must provide justification by email to email@example.com at least 10 days before the competition closes. We will decide whether to approve your request.
This competition is aimed at SMEs that have developed and manufactured innovative healthtech, including medical devices, diagnostics and regulated digital healthcare products.
You must have gained a CE marking for your product but not marketed it in the UK for more than 5 years. You must collect supporting clinical evidence of its performance, cost effectiveness and impact in the NHS. If we decide to fund you, this evidence may help increase uptake of your product within the NHS.
The competition will support the development or design of plans for the collection of clinical data in a real-world setting, and also support the running of these studies.
Your proposal must:
- describe the innovative or CE-marked device
- show how your product is likely to have a significant impact, including increasing patient access to innovative technologies where appropriate
- demonstrate how the product meets the priority needs, such as those defined in 'Next steps on the NHS 5 Year Forward View'
- provide evidence that you are working with appropriate stakeholders including NICE, NHS, NIHR and AHSNs
- outline how your study will allowing NICE to evaluate its data
Your project must:
- focus on understanding evidence gaps and testing product performance to explain the operational impact of your product on the NHS
- add data to the evidence base that can contribute to the health technology appraisal process, for instance by comparing the use of the new product with the current standard of care
- involve potential breakthrough technologies
- help improve methods and systems
Priority will be given to projects that:
- reduce cancellations or unnecessary appointments in primary and secondary care
- reduce the number of people that need to use A&E services
- improve patient safety and avoid patient harm
- speed up diagnosis, such as improving the scope of lower cost diagnostic imaging
- enable earlier diagnosis of cancer
- support the management of long term conditions, such as diabetes, chronic pain management, cardiovascular disease, asthma and chronic obstructive pulmonary disease (COPD)